Leerink Partners analyst Thomas Smith has reiterated their bullish stance on VKTX stock, giving a Buy rating yesterday. Thomas Smith has given his Buy rating due to a combination of factors, primarily ...

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Viking Therapeutics (VKTX – Research Report). The ...

Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic disorder X-linked adrenoleukodystrophy, or X-ALD.

It's been a strong day for Viking Therapeutics. Its shares are now trading at $67.11, marking a 6.5% change since the previous market close. An analyst favorite, the Pharmaceutical company has a ...

On Monday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $63.01 which represents a decrease of $-1.95 or -3.00% from the prior close of $64.96. The stock opened at $65.61 and ...

We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now. In this article, we are going to take a look at where ...

Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $64.11 which represents a decrease of $-0.58 or -0.90% from the prior close of $64.69. The stock opened at $64.6 and touched a low ...

Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company, is making significant strides in the ...

One of the current stars of the biotech world is Viking Therapeutics (NASDAQ: VKTX), and for good reason. The clinical-stage company is advancing to the later stages of developing a drug that, if ...

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, we are going to take a look ...